Fluimucil tosse grassa
Fluimucil tosse grassa is a medicine authorised by Swissmedic under authorisation number 55604. The authorisation holder is Zambon Svizzera SA. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 10 May 2001 and the authorisation is valid without a time limit. ATC code R05CB01 places the medicine in the group Cough and cold preparations.
| Authorisation number | 55604 |
|---|---|
| Name | Fluimucil tosse grassa |
| Full name | Fluimucil tosse grassa, compresse linguali |
| Authorisation holder | Zambon Svizzera SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | R05CB01 |
| First authorisation | 10 May 2001 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Fluimucil tosse grassa, compresse linguali | D | 10 May 2001 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 21 | 20 | Tablette(n) | R05CB01 | 03.02.0. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Fluimucil tosse grassa authorised in Switzerland?
Yes. Fluimucil tosse grassa is authorised by Swissmedic under authorisation number 55604, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Fluimucil tosse grassa have?
Fluimucil tosse grassa is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Fluimucil tosse grassa?
The authorisation holder is Zambon Svizzera SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.